VeriFone Systems, Inc. (PAY) managed to rebound with the stock climbing 2.6% or $0.47 to close the day at $18.57 on active trading volume of 2.43M shares, compared to its three month average trading volume of 2.17M. The San Jose California 95134 based company has been underperforming the business equipment group over the past 52 weeks, with the stock losing -17.17%, compared to the industry which has advanced 7.29% over the same period. With RSI of 56.63, the stock should still continue to rise and get closer to its one year target estimate of $18.88, making it a hold for now.
VeriFone Systems, Inc. provides payments and commerce solutions at the point of sale (POS) worldwide. It offers countertop solutions that accept payment options, such as contactless, NFC, mobile wallets, and EMV; PIN pads that support credit and debit card, EBT, EMV, and other PIN-based transactions; and multimedia consumer facing POS devices. The company also provides portable payment devices, including small, portable, and handheld devices that enable merchants to accept electronic payments wherever wireless connectivity is available; and mobile solutions that attach to and interface with iOS, Android, or Windows-based smartphones and tablets. In addition, it offers integrated electronic payment systems that combine electronic payment processing, fuel dispensing, and ECR functions, as well as secure payment systems for integration with petroleum pump controllers; unattended and self-service payment solutions designed to enable payment transactions in self-service, high-transaction volume, and public transportation environments; and network access solutions. Further, the company provides other managed, terminal management, payment-enabled media, in-taxi payment, and security solutions; and server-based payment processing software and middleware. Additionally, it offers installation, deployment, training, and application development and delivery solutions; project management, client education program, and consulting services; helpdesk support, equipment repair and maintenance, and software post-contract support services; and application libraries and development tools. The company sells its products directly; and through third party distributors and partners. It serves financial services, retail, petroleum, restaurant, hospitality, taxi, transportation, and healthcare industries. The company was formerly known as VeriFone Holdings, Inc. and changed its name to VeriFone Systems, Inc. in May 2010. VeriFone Systems, Inc. is headquartered in San Jose, California.
Amgen Inc. (AMGN) grew with the stock adding 0.63% or $0.97 to close at $155.77 on light trading volume of 2.43M compared its three months average trading volume of 4.2M. The Thousand Oaks California 91320 based company operating under the Biotechnology industry has been trending up for the last 52 weeks, with the shares price now 5.67% up for the period and up by 6.54% so far this year. With price target of $181.73 and a 17.35% rebound from 52-week low, Amgen Inc. has plenty of upside potential, making it a hold with a view buy.
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It offers products for the treatment of illness in the areas of oncology/hematology, cardiovascular, inflammation, bone health, nephrology, and neuroscience. The companys products include Neulasta, a pegylated protein for the treatment of cancer patients; NEUPOGEN, a recombinant-methionyl human granulocyte colony-stimulating factor for reducing the incidence of infection for patients with non-myeloid malignancies; and Enbrel to treat rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis. Its products also comprise EPOGEN to treat a lower-than-normal number of red blood cells caused by chronic kidney disease (CKD) in patients on dialysis; Aranesp for treating anemia; XGEVA for the prevention of skeletal-related events; Prolia to treat postmenopausal women with osteoporosis; Repatha for the treatment of cholesterol; and Sensipar/Mimpara products for use in the treatment of secondary hyperparathyroidism in CKD patients on dialysis. The companys other marketed products include Kyprolis, a proteasome inhibitor to treat patients with multiple myeloma and small-cell lung cancer; Nplate, a thrombopoietic compound; Vectibix, a human monoclonal antibody; and BLINCYTO for the treatment of patients with Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia. It also develops various products that are in various clinical trials. The company serves pharmaceutical wholesale distributors; and physicians or their clinics, dialysis centers, hospitals, and pharmacies, as well as consumers. It has collaborative agreements with Xencor, Inc; UCB; Novartis AG; Bayer HealthCare Pharmaceuticals Inc; Advaxis, Inc.; Dr. Reddys Laboratories Ltd.; Biocartis Group NV; and Nuevolution AB. The company also has a strategic collaboration with Immatics Biotechnologies GmbH. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.
PBF Energy Inc. (PBF) failed to extend gains with the stock declining -0.69% or $-0.17 to close the day at $24.38 on lower than average trading volume of 2.43M shares, compared to its three month average trading volume of 2.62M. The Parsippany New Jersey 07054 based company has been outperforming the oil & gas refining & marketing companies by 18.7445% for last three months and its recent gains have offset losses to -12.55% YTD, versus the oil & gas refining & marketing industry which is down -1.63% for the same period. The RSI of 40.01 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.
PBF Energy Inc., together with its subsidiaries, engages in the refining and supply of petroleum products. It produces gasoline, ultra-low-sulfur diesel, heating oil, diesel fuel, jet fuel, lubricants, petrochemicals, and asphalt, as well as unbranded transportation fuels, petrochemical feedstocks, blending components, and other petroleum products. The company sells its products in Northeast and Midwest of the United States, as well as in other regions of the United States and Canada. PBF Energy Inc. was founded in 2008 and is based in Parsippany, New Jersey.